These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

22 related articles for article (PubMed ID: 12964551)

  • 1. Commentary--Defined contribution health plans: attracting the healthy and well-off.
    Shearer G
    Health Serv Res; 2004 Aug; 39(4 Pt 2):1159-66. PubMed ID: 15230918
    [No Abstract]   [Full Text] [Related]  

  • 2. Commentary--How consumer-driven health care evolves in a dynamic market.
    Scandlen G
    Health Serv Res; 2004 Aug; 39(4 Pt 2):1113-8. PubMed ID: 15230914
    [No Abstract]   [Full Text] [Related]  

  • 3. Commentary--Current MSA theory: well-meaning but futile.
    Halvorson GC
    Health Serv Res; 2004 Aug; 39(4 Pt 2):1119-22. PubMed ID: 15230915
    [No Abstract]   [Full Text] [Related]  

  • 4. Control of prescription costs--is it possible?
    Renaud PN
    Empl Benefits J; 2002 Mar; 27(1):11-4. PubMed ID: 11859536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Commentary--Looking at the effects of consumer-centric health plans on expenditures and utilization.
    Bertko J
    Health Serv Res; 2004 Aug; 39(4 Pt 2):1211-8. PubMed ID: 15230921
    [No Abstract]   [Full Text] [Related]  

  • 6. Insurance benefits, out-of-pocket payments, and the demand for medical care.
    Newhouse JP
    Health Med Care Serv Rev; 1978; 1(4):1, 3-15. PubMed ID: 10297475
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacy benefit management companies: dimensions of performance.
    Lipton HL; Kreling DH; Collins T; Hertz KC
    Annu Rev Public Health; 1999; 20():361-401. PubMed ID: 10352863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experience of state drug benefit programs.
    Soumerai SB; Ross-Degnan D
    Health Aff (Millwood); 1990; 9(3):36-54. PubMed ID: 2227783
    [No Abstract]   [Full Text] [Related]  

  • 9. Defined-contribution products and their influence on pharmacy benefit management.
    Giaquinta D
    Manag Care Interface; 2003 Aug; 16(8):36-8. PubMed ID: 12964551
    [No Abstract]   [Full Text] [Related]  

  • 10. Economic and clinical impact of innovative pharmacy benefit designs in the management of diabetes pharmacotherapy.
    Berger J
    Am J Manag Care; 2007 Apr; 13 Suppl 2():S55-8. PubMed ID: 17417934
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.